In Vitro and In Vivo Efficacies of the Linear and the Cyclic Version of an All-<span style="font-variant: small-caps">d</span>-Enantiomeric Peptide Developed for the Treatment of Alzheimer’s Disease

In Vitro and In Vivo Efficacies of the Linear and the Cyclic Version of an All-<span style="font-variant: small-caps">d</span>-Enantiomeric Peptide Developed for the Treatment of Alzheimer’s Disease

Multiple sources of evidence suggest that soluble amyloid β (Aβ)-oligomers are responsible for the development and progression of Alzheimer’s disease (AD). In order to specifically eliminate these toxic Aβ-oligomers, our group has developed a variety of all-<span style="font-variant: small-c...

Full description

Bibliographic Details
Main Authors: Sarah Schemmert, Luana Cristina Camargo, Dominik Honold, Ian Gering, Janine Kutzsche, Antje Willuweit, Dieter Willbold
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:International Journal of Molecular Sciences
Subjects:
Alzheimer’s disease
<span style="font-variant: small-caps">d</span>-peptides
treatment
behavior
Tg-SwDI mice
cognition
Online Access:https://www.mdpi.com/1422-0067/22/12/6553

Internet

https://www.mdpi.com/1422-0067/22/12/6553

Similar Items